Calendar Arbutus Biopharma Corporation
Stocks
ABUS
CA03879J1003
Advanced Medical Equipment & Technology
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.560 USD | -3.80% |
|
-5.00% | -5.20% |
| Jul. 16 | Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech -- Update | DJ |
| Jul. 16 | Arbutus Files More Patent Infringement Suits Against Pfizer, BioNTech | DJ |
Chart calendar Arbutus Biopharma Corporation
Upcoming events on Arbutus Biopharma Corporation
No events available
Past events on Arbutus Biopharma Corporation
| 2026-05-26 | Annual General Meeting | 01:00 pm |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 24,6 28,3 -13.05% | 8,80 8,72 0.9% | 19,3 18,9 2.27% | 249 | 3,71 |
|
EBITDA | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 |
|
EBIT Million CAD | Released Forecast Spread | -106 -108 2.15% | -109 -113 3.34% | -52,3 -55,5 5.66% | 210 | -29,3 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -98,9 -101 2.23% | -99,7 -103 3.31% | -46,0 -49,9 7.87% | 214 | -24,9 |
|
Net income Million CAD | Released Forecast Spread | -98,9 -99,8 0.86% | -99,7 -103 3.31% | -46,0 -49,9 7.87% | 214 | -24,9 |
|
EPS CAD | Released Forecast Spread | -0,60 -0,61 1.69% | -0,54 -0,55 1.05% | -0,23 -0,26 11.33% | 1,03 | -0,12 |
| Announcement Date | 29/02/24 | 27/03/25 | 23/03/26 | - |
Quarterly results
| Fiscal Period | March | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million CAD | Released Forecast Spread | 1,86 2,57 -27.91% | 2,25 2,21 1.69% | 2,46 2,29 7.78% | 14,8 2,21 568.76% | 0,74 1,31 -43.46% | 1,44 0,83 73.92% | 246 1,53 15954.65% | 0,96 | 0,96 | 0,96 | 0,96 | 0,96 | 0,96 | 0,96 |
|
EBIT Million CAD | Released Forecast Spread | -29,7 -27,3 -8.93% | -19,9 -24,6 19.08% | -35,9 -27,3 -31.34% | 2,05 -8,24 124.89% | -12,1 -7,57 -60.24% | -7,26 -9,39 22.71% | 232 -6,82 3498.97% | -7,28 | -7,28 | -7,28 | -7,28 | -7,28 | -7,28 | -7,28 |
|
Earnings before Tax (EBT) Million CAD | Released Forecast Spread | -27,3 -24,8 -10.3% | -17,9 -22,1 19.24% | -34,3 -25,3 -35.42% | 3,48 -6,71 151.86% | -10,8 -6,05 -79.11% | -5,15 -8,13 36.6% | 233 -4,59 5170.89% | -6,18 | -6,18 | -6,18 | -6,18 | -6,18 | -6,18 | -6,18 |
|
Net income Million CAD | Released Forecast Spread | -27,3 -24,8 -10.26% | -17,9 -22,1 19.24% | -34,3 -25,3 -35.42% | 3,48 -6,71 151.86% | -10,8 -6,05 -79.11% | -5,15 -8,13 36.6% | 233 -4,59 5170.89% | -6,18 | -6,18 | -6,18 | -6,18 | -6,18 | -6,18 | -6,18 |
|
EPS CAD | Released Forecast Spread | -0,14 -0,13 -6.91% | -0,10 -0,11 11.48% | -0,18 -0,15 -22.23% | 0,01 -0,07 120.8% | -0,06 -0,04 -34.96% | -0,01 -0,05 71.71% | 1,19 -0,03 4363.61% | -0,03 | -0,03 | -0,03 | -0,03 | -0,03 | -0,03 | -0,03 |
| Announcement Date | 06/11/24 | 27/03/25 | 14/05/25 | 06/08/25 | 13/11/25 | 23/03/26 | 13/05/26 | - | - | - | - | - | - | - |
| 2026-07-30 | Earnings release - Q2 2026 | ||
| 2026-07-30 | Earnings presentation | 08:30 am | |
| 2026-08-06 | Earnings release - Q2 2026 | ||
| 2026-08-06 | Earnings presentation | 08:00 am | |
| 2026-08-13 | Earnings release - Q2 2026 | 01:30 am | |
| 2026-08-17 | Earnings release - Annual 2026 | P | |
| 2026-08-17 | Earnings presentation | 09:00 pm | |
| 2026-08-27 | Annual General Meeting | ||
| 2026-08-29 | Earnings release - Q2 2026 | ||
| 2026-09-01 | Ex-dividend date - 0.04 HKD | 12:00 am |
Past sector events for Arbutus Biopharma Corporation
| 2026-06-29 | Board of Directors Meeting | ||
| 2026-06-29 | Earnings release - Annual 2026 | ||
| 2026-06-27 | Board of Directors Meeting | ||
| 2026-06-27 | Earnings release - Annual 2026 | ||
| 2026-06-25 | Annual General Meeting | 09:30 pm | |
| 2026-06-17 | Présentation aux Actionnaires / Analystes | 12:00 pm | |
| 2026-06-17 | Annual General Meeting | 12:00 pm | |
| 2026-06-16 | Présentation aux Actionnaires / Analystes | 11:00 am | |
| 2026-06-15 | Annual General Meeting | ||
| 2026-06-15 | Ex-dividend date - 0.03 CNY | 12:00 am |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- ABUS Stock
- Calendar Arbutus Biopharma Corporation
Select your edition
All financial news and data tailored to specific country editions
















